Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?— results of a study in 50 patients
- 1 November 1999
- Vol. 54 (5) , 900-904
- https://doi.org/10.1016/s0090-4295(99)00272-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Positron emission tomography as a diagnostic tool in oncologyEuropean Radiology, 1998
- RETROPERITONEAL LYMPHADENECTOMY IN STAGING AND TREATMENTUrologic Clinics of North America, 1998
- STAGING OF TESTIS CANCER: Combining Serum Markers, Histologic Parameters, and Radiographic ImagingUrologic Clinics of North America, 1998
- CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria.American Journal of Roentgenology, 1997
- Detection of residual tumours in postchemotherapy testicular cancer by FDG-PETEuropean Journal Of Cancer, 1997
- Skin TumoursPublished by Springer Nature ,1997
- Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography.Radiology, 1995
- Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumorsUrology, 1994
- Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Quantitation in Positron Emission Computed TomographyJournal of Computer Assisted Tomography, 1979